oleic acid has been researched along with Prostatic Neoplasms in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (31.58) | 18.2507 |
| 2000's | 5 (26.32) | 29.6817 |
| 2010's | 8 (42.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beguinot, F; Calì, G; Conza, D; Cosimato, V; Formisano, P; Insabato, L; Liotti, A; Luongo, G; Mirra, P; Secondo, A; Terracciano, D; Ulianich, L | 1 |
| Bassett, JK; English, DR; Gibson, RA; Giles, GG; Hodge, AM; Hopper, JL; MacInnis, RJ; Severi, G | 1 |
| Hagen, RM; Ladomery, MR; Rhodes, A | 1 |
| Kızılşahin, S; Nalbantsoy, A; Yavaşoğlu, NÜ | 1 |
| Bishop, KS; Erdrich, S; Ferguson, LR; Han, DY; Jesuthasan, A; Karunasinghe, N; Zhu, S | 1 |
| Li, X; Lih, FB; McEntee, MF; Neilsen, N; O'Rourke, D; Ray, M; Reel, D; Shoieb, A; Tomer, K; Whelan, J; Ziegler, C | 1 |
| Fang, Y; Gao, X; Guo, W; Ling, Y; Liu, W; Luo, Y; Pang, J; Wei, K; Wen, X | 1 |
| Alijanvand, HH; Atri, MS; Goliaei, B; Moosavi-Movahedi, AA; Niasari-Naslaji, A; Saboury, AA; Sefidbakht, Y; Sharifzadeh, A | 1 |
| Aiken, WD; Bennett, FI; Coard, KC; Jackson, MD; Lindsay, CM; McFarlane-Anderson, N; Paul, TJ; Simpson-Smith, CM; Smith, G; Tulloch, T; Walker, SP; Wan, RL | 1 |
| Bougnoux, P; Menanteau, J | 1 |
| Bidaisee, LA; Bryskine, I; Gupta, RS; Lin, H; Lu, JP; Pinthus, JH; Singh, G | 1 |
| Choi, YK; Flanigan, RC; Freeman, VL; Kositsawat, J; Meydani, M | 1 |
| Campos, H; Chavarro, JE; Kurth, T; Ma, J; Stampfer, MJ; Willett, WC | 1 |
| Chaudry, AA; Dutta-Roy, AK | 1 |
| du Plessis, DJ; du Toit, PJ; van Aswegen, CH | 1 |
| Ali, K; Lubaroff, D; McCaw, R; Olsen, J; Robbins, M; Vartak, S | 1 |
| Becker, PJ; du Plessis, DJ; du Toit, PJ; Motaung, E; Prinsloo, SE; van Aswegen, CH | 1 |
| Chaudry, A; McClinton, S; Moffat, LE; Wahle, KW | 1 |
| Gillatt, DA; Habib, NA; Heinemann, D; Persad, RA; Smith, PJ | 1 |
1 review(s) available for oleic acid and Prostatic Neoplasms
| Article | Year |
|---|---|
[Dietary fatty acids and experimental carcinogenesis].
Topics: alpha-Linolenic Acid; Animals; Colonic Neoplasms; Dietary Fats; Dietary Fats, Unsaturated; Fatty Acids; Fatty Acids, Omega-3; Fatty Acids, Omega-6; Fatty Acids, Unsaturated; Female; Fish Oils; Humans; Linoleic Acid; Male; Mammary Neoplasms, Experimental; Models, Animal; Neoplasm Transplantation; Neoplasms, Experimental; Oleic Acid; Prostatic Neoplasms; Rodentia | 2005 |
1 trial(s) available for oleic acid and Prostatic Neoplasms
| Article | Year |
|---|---|
A prospective study of trans-fatty acid levels in blood and risk of prostate cancer.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Humans; Linoleic Acid; Male; Middle Aged; Oleic Acid; Prospective Studies; Prostatic Neoplasms; Risk Factors; Surveys and Questionnaires; United States | 2008 |
17 other study(ies) available for oleic acid and Prostatic Neoplasms
| Article | Year |
|---|---|
Oleic acid promotes prostate cancer malignant phenotype via the G protein-coupled receptor FFA1/GPR40.
Topics: Aged; Cell Line, Tumor; Cell Proliferation; Cell Survival; Docetaxel; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Male; Middle Aged; Oleic Acid; Phenotype; Phosphatidylinositol 3-Kinases; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Receptors, G-Protein-Coupled; RNA, Messenger; Signal Transduction | 2018 |
Plasma phospholipid fatty acids, dietary fatty acids and prostate cancer risk.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Cohort Studies; Diet; Dietary Fats; Fatty Acids; Fatty Acids, Monounsaturated; Fatty Acids, Omega-6; Female; Humans; Linoleic Acid; Male; Middle Aged; Oleic Acid; Palmitic Acid; Phospholipids; Prospective Studies; Prostatic Neoplasms; Risk Factors; Surveys and Questionnaires | 2013 |
Conjugated linoleate reduces prostate cancer viability whereas the effects of oleate and stearate are cell line-dependent.
Topics: Acetyl-CoA Carboxylase; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Fatty Acid Synthase, Type I; Gene Expression; Glycerol-3-Phosphate O-Acyltransferase; Humans; Linoleic Acids, Conjugated; Lipid Metabolism; Male; Oleic Acid; PPAR gamma; Prostatic Neoplasms; Stearic Acids | 2013 |
In vitro synergistic efficacy of conjugated linoleic acid, oleic acid, safflower oil and taxol cytotoxicity on PC3 cells.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Drug Synergism; Humans; Linoleic Acids, Conjugated; Male; Oleic Acid; Paclitaxel; Prostatic Neoplasms; Safflower Oil | 2015 |
An investigation into the association between DNA damage and dietary fatty acid in men with prostate cancer.
Topics: Aged; Body Mass Index; C-Reactive Protein; Cohort Studies; Dairy Products; Diet; Diet Records; Diet, Mediterranean; Diet, Western; Dietary Fats; DNA Damage; Fatty Acids; Fatty Acids, Omega-3; Fatty Acids, Omega-6; Fish Oils; Humans; Male; Meat; Middle Aged; New Zealand; Oleic Acid; Olive Oil; Plant Oils; Prostatic Neoplasms | 2015 |
Dietary n-3 polyunsaturated fatty acids enhance hormone ablation therapy in androgen-dependent prostate cancer.
Topics: Androgen Antagonists; Animals; Apoptosis; Arachidonic Acid; Blotting, Western; Dietary Fats, Unsaturated; Drug Resistance, Neoplasm; Eicosanoids; Eicosapentaenoic Acid; Fatty Acids, Unsaturated; Humans; Linoleic Acid; Male; Mice; Neoplasms, Hormone-Dependent; Oleic Acid; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Spectrometry, Mass, Electrospray Ionization; Xenograft Model Antitumor Assays | 2008 |
Docetaxel loaded oleic acid-coated hydroxyapatite nanoparticles enhance the docetaxel-induced apoptosis through activation of caspase-2 in androgen independent prostate cancer cells.
Topics: Androgens; Antineoplastic Agents; Apoptosis; Blotting, Western; Caspase 2; Cell Cycle; Cell Line, Tumor; Cell Survival; Cysteine Endopeptidases; Docetaxel; Drug Carriers; Drug Compounding; Durapatite; Enzyme Activation; Flow Cytometry; Humans; Male; Membrane Potential, Mitochondrial; Nanoparticles; Oleic Acid; Particle Size; Prostatic Neoplasms; RNA, Small Interfering; Taxoids | 2010 |
Structure and stability analysis of cytotoxic complex of camel α-lactalbumin and unsaturated fatty acids produced at high temperature.
Topics: Antineoplastic Agents; Calcium; Cell Line, Tumor; Circular Dichroism; Computer-Aided Design; Drug Design; Drug Discovery; Hot Temperature; Humans; Lactalbumin; Linoleic Acid; Male; Oleic Acid; Prostatic Neoplasms; Protein Conformation; Protein Folding; Protein Stability; Protein Structure, Secondary; Spectrometry, Fluorescence; Tubulin | 2011 |
Associations of whole-blood fatty acids and dietary intakes with prostate cancer in Jamaica.
Topics: Adult; Aged; Aged, 80 and over; alpha-Linolenic Acid; Biomarkers, Tumor; Case-Control Studies; Dietary Fats, Unsaturated; Fatty Acids; Fatty Acids, Monounsaturated; Feeding Behavior; Humans; Jamaica; Male; Middle Aged; Oleic Acid; Persea; Prostatic Neoplasms; Risk Factors | 2012 |
Androgen-dependent regulation of medium and long chain fatty acids uptake in prostate cancer.
Topics: Adenocarcinoma; Androgen Antagonists; Androgens; Anilides; Aspartate Aminotransferase, Mitochondrial; Blotting, Western; Cell Line, Tumor; Fatty Acid-Binding Proteins; Fatty Acids; Flow Cytometry; Humans; Male; Metribolone; Microscopy, Confocal; Neoplasms, Hormone-Dependent; Nitriles; Oleic Acid; Prostatic Neoplasms; Tosyl Compounds; Up-Regulation | 2007 |
The ratio of oleic-to-stearic acid in the prostate predicts biochemical failure after radical prostatectomy for localized prostate cancer.
Topics: Aged; Biomarkers; Cohort Studies; Disease-Free Survival; Follow-Up Studies; Humans; Logistic Models; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Obesity; Oleic Acid; Predictive Value of Tests; Proportional Hazards Models; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Retrospective Studies; Risk Factors; Statistics, Nonparametric; Stearic Acids; Survival Analysis | 2007 |
Purification and characterization of a fatty acid binding protein from human prostatic tissue.
Topics: Amino Acids; Arachidonic Acid; Carrier Proteins; Chromatography, Gel; Electrophoresis, Polyacrylamide Gel; Fatty Acid-Binding Protein 7; Fatty Acid-Binding Proteins; Fatty Acids; Humans; Isoelectric Point; Male; Molecular Weight; Neoplasm Proteins; Oleic Acid; Oleic Acids; Prostate; Prostatic Diseases; Prostatic Neoplasms; Tumor Suppressor Proteins | 1993 |
The effect of essential fatty acids on growth and urokinase-type plasminogen activator production in human prostate DU-145 cells.
Topics: Cell Adhesion; Cell Division; Dose-Response Relationship, Drug; Fatty Acids, Essential; Fatty Acids, Unsaturated; Humans; Male; Oleic Acid; Prostatic Neoplasms; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator | 1996 |
gamma-linolenic acid (GLA)-mediated cytotoxicity in human prostate cancer cells.
Topics: Cell Division; Cell Survival; Fatty Acids, Omega-6; Fatty Acids, Unsaturated; gamma-Linolenic Acid; Humans; Male; Oleic Acid; Prostatic Neoplasms; Tumor Cells, Cultured | 1999 |
Cytotoxicity of combined essential fatty acids on a human prostate cancer cell line.
Topics: alpha-Linolenic Acid; Antineoplastic Agents; Arachidonic Acid; Cell Death; Drug Interactions; Fatty Acids, Essential; Fatty Acids, Unsaturated; gamma-Linolenic Acid; Humans; Male; Oleic Acid; Prostatic Neoplasms; Tumor Cells, Cultured | 1999 |
Essential fatty acid distribution in the plasma and tissue phospholipids of patients with benign and malignant prostatic disease.
Topics: Arachidonic Acid; Fatty Acids, Essential; Humans; Male; Oleic Acid; Oleic Acids; Phospholipids; Prostatic Diseases; Prostatic Neoplasms; Stearic Acids | 1991 |
Erythrocyte stearic to oleic acid ratio in prostatic carcinoma.
Topics: Biomarkers, Tumor; Erythrocyte Membrane; Hormones; Humans; Male; Oleic Acid; Oleic Acids; Prostatic Neoplasms; Stearic Acids | 1990 |